Tectonic Therapeutic, Inc.(TECX)

Biotechnology · Watertown, MA

$22.41-0.70 (-3.03%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T22:13:43.981Z.

Stored calculation inputs

Calculation as of: 2026-10-06T22:13:43.981Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -4.57
Quote price: 22.41

FMP input reference: 667dd3b64d3a271f66e92979ae52668ccbc7e2b5b2cdee7c8377401ac3ef4785

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

TECX Earnings Yield Metrics

EARNINGS YIELD

N/A

TECX Competitors' Earnings Yield

TECX

Tectonic Therapeutic, Inc.

Current

Market Cap

$422.86M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TLRY

Tilray Brands, Inc.

vs TECX

Market Cap

$422.72M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NEO

NeoGenomics, Inc.

vs TECX

Market Cap

$424.10M

Earnings Yield

N/A

TTM Avg

4.67%

3Y Avg

2.17%

5Y Avg

1.96%

PRTA

Prothena Corporation plc

vs TECX

Market Cap

$419.87M

Earnings Yield

N/A

TTM Avg

3.29%

3Y Avg

3.29%

5Y Avg

3.29%

SPRY

ARS Pharmaceuticals, Inc.

vs TECX

Market Cap

$426.51M

Earnings Yield

N/A

TTM Avg

0.52%

3Y Avg

0.52%

5Y Avg

0.52%

EDIT

Editas Medicine, Inc.

vs TECX

Market Cap

$418.95M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SENS

Senseonics Holdings, Inc.

vs TECX

Market Cap

$416.27M

Earnings Yield

N/A

TTM Avg

14.15%

3Y Avg

14.15%

5Y Avg

14.15%

RZLT

Rezolute, Inc.

vs TECX

Market Cap

$415.98M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NPCE

NeuroPace, Inc.

vs TECX

Market Cap

$431.97M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MPLT

MapLight Therapeutics, Inc.

vs TECX

Market Cap

$411.21M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Tectonic Therapeutic, Inc. (TECX)	$422.86M	N/A	N/A	N/A	N/A
Tilray Brands, Inc. (TLRY)vs ›	$422.72M	N/A	N/A	N/A	N/A
NeoGenomics, Inc. (NEO)vs ›	$424.10M	N/A	4.67%	2.17%	1.96%
Prothena Corporation plc (PRTA)vs ›	$419.87M	N/A	3.29%	3.29%	3.29%
ARS Pharmaceuticals, Inc. (SPRY)vs ›	$426.51M	N/A	0.52%	0.52%	0.52%
Editas Medicine, Inc. (EDIT)vs ›	$418.95M	N/A	N/A	N/A	N/A
Senseonics Holdings, Inc. (SENS)vs ›	$416.27M	N/A	14.15%	14.15%	14.15%
Rezolute, Inc. (RZLT)vs ›	$415.98M	N/A	N/A	N/A	N/A
NeuroPace, Inc. (NPCE)vs ›	$431.97M	N/A	N/A	N/A	N/A
MapLight Therapeutics, Inc. (MPLT)vs ›	$411.21M	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

About Tectonic Therapeutic, Inc.

Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator aimed at fibrosis, and various other GPCR modulators. Tectonic Therapeutic, Inc. is situated in Watertown, Massachusetts.

Watertown, MA

60 employees

tectonictx.com

Healthcare / Biotechnology